Physician profile
William A Gray
NPI 1720165640
$753,302.55
in general payments reported to CMS, 2019-2025
43 companies · $133K in 2025
The $133K reported for 2025 was more than what 99% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $135K · 2020: $74K · 2021: $82K · 2022: $110K · 2023: $107K · 2024: $112K · 2025: $133K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $233K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $49K · Food and Beverage: $19K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $233,353.67 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,625.65 |
| Travel and Lodging | $49,348.49 |
| Food and Beverage | $18,590.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $200,002.93 | 2019-2025 | (9520) Igt Devices Undivided, Peripheral Vascular Undivided, Igt Devices Undivided |
| W. L. Gore & Associates, INC. | $136,206.22 | 2019-2025 | Gore Viabahn Endoprosthesis With Heparin, Viatorr Endoprosthesis, Gore Propaten Vascular Graft |
| Boston Scientific Corporation | $108,783.15 | 2019-2025 | Versacross Access Solution, General - Therapies, Angiojet Ultra 5000a |
| Shockwave Medical, INC | $80,782.84 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $55,524.39 | 2021-2025 | In.Pact Admiral, Hawkone, Mo.Ma Ultra |
| Edwards Lifesciences Corporation | $37,533.50 | 2019-2025 | Pascal, Evoque |
| Surmodics, INC. | $28,199.07 | 2020-2023 | Pounce Thrombectomy, Pounce Thrombectomy System, Pounce Venous Thrombectomy System |
| Contego Medical, INC | $26,857.05 | 2020-2024 | |
| Intact Vascular, INC. | $24,072.13 | 2019 | |
| Medtronic Vascular, INC. | $13,585.18 | 2019-2020 | |
| Baylis Medical Company INC | $8,693.92 | 2019-2021 | |
| Penumbra, INC. | $8,400.00 | 2019 | |
| Cordis US Corp. | $8,216.67 | 2022-2024 | Angioguard, Endo, Precise Pro Rx |
| Cagent Vascular INC | $5,284.46 | 2020-2023 | Serrantor |
| Endologix LLC | $4,067.56 | 2019-2025 | Torus Stent Graft System, Endocross Device |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,050.41 | 2019-2025 | Xact, Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit |
| Inspiremd Ltd | $854.40 | 2023-2025 | Cguard Prime Carotid Stent System, Cguard |
| Siemens Medical Solutions USA, INC. | $648.97 | 2019-2022 | |
| Mercator Medsystems, INC. | $270.70 | 2021 | |
| Heartflow, INC. | $208.60 | 2022-2023 | Ffrct |
| Abbvie INC. | $206.85 | 2024 | |
| Centerline Biomedical INC. | $124.93 | 2021-2024 | |
| Devoro Medical INC. | $103.67 | 2021 | |
| Janssen Pharmaceuticals, INC | $99.55 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $77.46 | 2022-2024 | Camzyos, Eliquis |
| Novo Nordisk INC | $54.27 | 2025 | Ozempic, Wegovy |
| Cardiovascular Systems INC. | $52.31 | 2022-2023 | Diamondback Peripheral |
| Acist Medical Systems, INC. | $43.28 | 2023 | |
| Pfizer INC. | $40.49 | 2019 | |
| Getinge USA Sales, LLC | $39.19 | 2022 | |
| Imperative Care, INC | $34.64 | 2025 | Symphony Catheter |
| Vesper Medical | $32.59 | 2021 | |
| Abiomed | $26.77 | 2024 | Impella |
| Astrazeneca Pharmaceuticals Lp | $22.75 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $20.12 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $20.00 | 2019 | |
| Terumo Medical Corporation | $17.36 | 2020-2025 | Angio-Seal, Metacross Otw, Tr Band |
| Teleflex LLC | $15.90 | 2020 | |
| Biosense Webster, INC. | $14.25 | 2025 | Qdot Micro |
| Amgen INC. | $14.02 | 2021 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$300,015.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$61,919.50 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Gray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.